IBL International GmbH, Tecan Group Revenue

Biotechnology Research • Hamburg, Hamburg, Germany • 21-50 Employees

IBL International GmbH, Tecan Group revenue & valuation

Annual revenue	$10,500,000
Revenue per employee	$215,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$33,600,000
Total funding	No funding

Key Contacts at IBL International GmbH, Tecan Group

Dagmar Kasper

Managing Director

Mark Hünken

Head Of Product Development – In Vitro Diagnostics Ivd & Application Support

Kai Ohlroggen

Director Qa

Company overview

Headquarters	Flughafenstraße 52a, Hamburg, 22335, DE
Phone number	+49490405328910
Websites	ibl-international.com tecan.com
NAICS	541714
SIC	283
Keywords	Lc-Ms, Immunoassays, Assays, Saliva Diagnostics, In-Vitro Diagnostic, Ivdr, Elisa Platforms, Resolvex A200, Luminescence-Based Immunoassays
Founded	1983
Employees	21-50
Socials

IBL International GmbH, Tecan Group Email Formats

IBL International GmbH, Tecan Group uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@ibl-international.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@ibl-international.com	100%

About IBL International GmbH, Tecan Group

IBL International has nearly 30 years experience in development, production and sales of immunodiagnostic products, and is an expert in these fields. Our product portfolio contains enzyme-, radio- and luminescence immunoassays that covers over 1000 products in a broad range of in-vitro diagnostics for research and routine. These products are designed for manual use, but can be easily adapted for open automated systems. We also have a large selection of “niche products” for special applications to complete our product line. IBL International also focuses on special test systems outside of the standard routine diagnostic tests. For example, we carry immunoassays for the determination of Neurotransmitters or other biogenic amines, steroid hormones in saliva, HMGB1, Neopterin and assays for Alzheimer’s research. We are continuously refining our immunoassays to assure high quality and reliable products. IBL International has a widespread distribution network in over 90 countries. We support our national and international customers with our professional team of product managers and customer service professionals.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Head

Employees by Department

IBL International GmbH, Tecan Group has 30 employees across 9 departments.

Departments

Number of employees

Funding Data

IBL International GmbH, Tecan Group has never raised funding before.

IBL International GmbH, Tecan Group Tech Stack

Discover the technologies and tools that power IBL International GmbH, Tecan Group's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Microsoft Clarity

Analytics

Amazon S3

CDN

Amazon Web Services

PaaS

Amazon SES

Google Tag Manager

Tag managers

HTTP/3

Miscellaneous

PHP

Programming languages

HSTS

Security

JSS

Development

React

JavaScript frameworks

HubSpot

Marketing automation

Frequently asked questions

IBL International GmbH, Tecan Group is located in Hamburg, Hamburg, DE.

You can reach IBL International GmbH, Tecan Group at +49490405328910.

IBL International GmbH, Tecan Group generates an estimated annual revenue of $10,490,170. This revenue figure reflects the company's market position and business performance in its industry.

IBL International GmbH, Tecan Group has an estimated valuation of $33,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

IBL International GmbH, Tecan Group was founded in 1983, making it 43 years old. The company has established itself as a significant player in its industry over this time.

IBL International GmbH, Tecan Group has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.